Electronic Skin Market statistics and research analysis released in latest report Over the past few years, electronic skin technology has gained significant momentum. The technology finds a wide range of use-cases on account of its selfhealing characteristics and excellent stretching and self-powering abilities. Electronic skin and patches can be used for patients with prosthetics to provide a sense of touch. In addition, the products are increasingly gaining prominence in diagnostic and therapeutic applications. Global Market Insights, Inc., forecasts that global electronic skin market size will be worth more than US$16 billion by 2026, with rapid adoption in diabetes and cardiac monitoring applications. They find widespread use in health monitoring systems, drug delivery systems, and cosmetics, among other applications.
Electronic skin patches form an essential component of microcurrent facemasks. Technologically advanced microcurrent facemasks help deliver essential skincare nutrients to the layers of the skin. For instance, DSA aesthetics had developed a microcurrent facemask that acts as a transdermal drug delivery system to enable faster onset of action when required. Cosmetics application segment is projected to witness a CAGR of 14.9% over 2020-2026. Electro-active polymers, stretchable conductors, stretchable circuits, and photovoltaic systems are different components of an electric skin. Electro-active polymers are generally preferred over conventional electronic wearables owing to benefits such as up to 10 times more battery life, noiseless operation, and ultra-low power consumption. These stretchable polymers that can withstand up to 20% working strain for actuators. Electro-active polymers segment in electronic skin industry will grow at 14.6% up to 2026. Electronic skins are generally available as patches or electronic skin suits. Electronic patches product segment is slated to experience a CAGR of 14.8% during the projected timeframe. Electronic patches have the ability to monitor body vitals of an individual in real-time. The product is prominently used fpr health conditions such diabetes, cardiovascular diseases, pregnancy-related problems, fever, and smoking cessation. Based on the distribution channel, the market is bifurcated into B2B and B2C. B2B segment includes hospitals, cosmetic companies, research institutes, and wearable device manufacturers. Research institutes held about 40% revenue share during 1|Page